Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Lexicon Pharmaceuticals, Inc.
(NQ:
LXRX
)
2.260
USD
+0.050 (+2.26%)
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 18, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Lexicon Pharmaceuticals, Inc.
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Stocks Open Mixed as Retail Sales Surge
September 15, 2009
Retail sales rose by a better than expected 2.7% in August, but wholesale prices surged which worried some investors. The Dow slipped 4 points to 9622 while Nasdaq held steady at 2090.
Read More
category
Market News
from
MarketMinute.com Market Updates
Early Market Movers: Parallel Petroleum, B&G Foods
September 15, 2009
Early Market Movers: Parallel Petroleum, B&G Foods
Read More
category
Markets
from
FOXBusiness.com
Lexicon Pharma (LXRX) Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
September 15, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4943895 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
September 15, 2009
from
PR Newswire
Lexicon Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
September 09, 2009
from
PR Newswire
Lexicon Pharmaceuticals (LXRX) Files To Sell Up To $150M
September 02, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4919150 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare Conference
September 02, 2009
from
PR Newswire
Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis
August 04, 2009
from
PR Newswire
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 Second Quarter Financial Results
July 28, 2009
from
PR Newswire
Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2009 Financial Results on July 28, 2009
July 22, 2009
from
PR Newswire
Morning Movers 7/21: JDAS, PKG, INCY, LAB, LXRX, CGEN Higher; RF, LXK, IDIX, ZION, FWRD Lower
July 21, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4806979 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon Pharmaceuticals (LXRX) Receives Orphan Drug Designation From EMEA for LX1032
July 21, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4806005 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA
July 21, 2009
from
PR Newswire
Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome
July 07, 2009
from
PR Newswire
Lexicon Pharmaceuticals (LXRX) Names Ajay Bansal Executive Vice President and CFO
June 02, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4698880 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon Names Ajay Bansal Executive Vice President and Chief Financial Officer
June 02, 2009
from
PR Newswire
Lexicon to Present Clinical Data for LX1031 and LX1032 at Digestive Disease Week
May 27, 2009
from
PR Newswire
Lexicon Pharmaceuticals (LXRX) Misses Q1 View By 3c
April 28, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4592751 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2009 First Quarter Results
April 28, 2009
from
PR Newswire
Lexicon to Provide Clinical Pipeline Update and Report First Quarter 2009 Financial Results on April 28, 2009
April 21, 2009
from
PR Newswire
Lexicon Pharmaceuticals 2008 Annual Report to Stockholders Available Online
March 13, 2009
from
PR Newswire
Lexicon Presents Clinical Data on LX1032 for Carcinoid Syndrome at European Neuroendocrine Tumor Society Meeting
March 05, 2009
from
PR Newswire
Lexicon Pharmaceuticals Reports 2008 Fourth Quarter and Full Year Financial Results
February 25, 2009
Conference Call and Webcast At 11:00 a.m. Eastern Time
Read More
from
GlobeNewswire News Releases
Lexicon to Report Fourth Quarter and Year End 2008 Financial Results On February 25, 2009
February 18, 2009
Conference Call and Webcast to Follow
Read More
from
GlobeNewswire News Releases
Lexicon Pharmaceuticals (LXRX) Announces 22% Reduction in Workforce
January 22, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4323514 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon Consolidates Operations to Focus Resources On Most Advanced Drug Discovery and Development Programs
January 22, 2009
from
GlobeNewswire News Releases
Zacks Analyst Blog Highlights: Zoran Corporation, Kinross Gold Corp., Lexicon Pharmaceuticals Inc., Aracruz Celulose S.A. and Votortantim Celulose S.A.
January 13, 2009
from
Business Wire News Releases
Lexicon Pharma (LXRX) Initiates Phase 2 Trial of LX1031
January 12, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4293574 for the full story.
Read More
from
StreetInsider.com News Articles
Lexicon Initiates Phase 2 Clinical Trial of LX1031 in Patients With Irritable Bowel Syndrome
January 12, 2009
Novel Mechanism Designed to Reduce Gastrointestinal Serotonin Production
Read More
from
GlobeNewswire News Releases
Lexicon Pharmaceuticals to Present At the 27th Annual JPMorgan Healthcare Conference
January 08, 2009
from
GlobeNewswire News Releases
< Previous
1
2
...
11
12
13
14
15
16
17
18
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here